Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway”

Contract type	Supplies
CPV	33600000
Awarded to	Urtica Sp. z o.o.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.